HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Physicians Formula Goes To Wet N Wild Owner Markwins For $75 Mil.

This article was originally published in The Rose Sheet

Executive Summary

Markwins International has acquired Physicians Formula Holdings, offering roughly $10 million more than previous suitor Swander Pace Capital. The merger “will strengthen the combined portfolio of brands,” Physicians Formula CEO Ingrid Jackel says.

You may also be interested in...

Markwins Acquires Bonne Bell, Lip Smacker In Bid For Youth Market

Deal with Aspire Brands, expected to close this month, will round out Markwins’ portfolio, which includes wet n wild, Physicians Formula and Black Radiance cosmetics, enabling it to cater to “beauty consumers of all demographics, inclusive of age, ethnicity, lifestyle and preference,” the firm says.

In Brief

Swander Pace picks up gloProfessional; Dr. Hauschka promotes its natural/organic portfolio and NATRUE certification. More news in brief.

In Brief

Markwins finishes acquiring Physicians Formula; L’Oreal opens its second hair-color plant in Mexico. More news in brief.

Related Content


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts